2002]. A separate study has compared methadone and heroin effects on hERG, reporting the latter to be ~100-fold less potent than methadone [Zunkler et al.

2010]. Chlorobutanol has been suggested to potentiate the ability of methadone to inhibit hERG current [Kornick et al. 2003] and diazepam has been suggested to exacerbate hERG-blocking effects of methadone by alleviating methadone block of sodium channels and, thereby, reducing any compensatory effect of sodium channel block on hERG inhibition [Kuryshev et al. 2010]. Case report format Rather than attempting to develop a database that can be analyzed using parametric Inhibitors,research,lifescience,medical statistics, we employed the principles of narrative Inhibitors,research,lifescience,medical medicine in a case report format as

we have in our other papers assessing psychotropic drug-induced QTc interval prolongation and TdP [Vieweg, 2003; Vieweg et al. 2004; Vieweg et al. 2005; Vieweg et al. 2009; Vieweg et al. 2012]. Data from our review of case reports in the literature and analyses of those data form the body of our paper. Methods On January 8, Inhibitors,research,lifescience,medical 2012, we entered “methadone and QT prolongation” (81 articles), “methadone and QTc” (71 articles) and then “methadone and torsade” (38 articles) into PubMed limiting our selections to those in English. From these findings, we found 20 case reports in the literature and 12 additional case reports referenced in this literature (one was not in English). Results Vital information from these 32 case reports appears in Table Inhibitors,research,lifescience,medical 1. Nineteen subjects were men (age 44.4±12.9, range 22-61 years). Twelve subjects were women (age 46.3±7.0, range 36-61 years). One subject was a female newborn. Table 1. Case report risk factors for QTc interval prolongation and torsade Inhibitors,research,lifescience,medical de pointes (TdP) Cases in red formed the 21 patients allowing a correlation between QTc interval

prolongation and methadone dose. Based on current evidence reviewed in this paper, risk … Among the 21 subjects—nine men and 12 women—(Table 1—patients Dacomitinib 1, 6, 7, 9-14, 18-28 and 31 cases are printed in red) (1) developing TdP, (2) having QTc interval measurements in close proximity to the time they developed this arrhythmia and (3) having daily methadone doses recorded at the time of TdP, there were insignificant correlations between QTc interval and methadone dose using both parametric and nonparametric statistics (Pearson r = −0.263, p = 0.249, Kendall’s tau_b −0.39, p = 0.808, Regorafenib order Spearman’s rho = 0.005, p = 0.982). When we assessed the correlation between methadone dose and total risk factors (Table 1), we again found an insignificant inverse relationship using both parametric and nonparametric statistics (Pearson r = −0.084, p = 0.663, Kendall’s tau_b −0.46, p = 0.744, Spearman’s rho = −0.071, p = 0.714).